The Patent Finder

Delinia, Inc.

Also on record
Records under this name other than the patents Delinia, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 6 of 6 · Back to Delinia, Inc.

PatentTitleStatus Expires Confidence
US 10,035,836Modified IL-2 Variants That Selectively Activate Regulatory T Cells
Lapsed on the fee record
Ended Jul 31, 2026 · High confidence
Lapsed on the fee recordEnded Jul 31, 2026High confidence
US 11,077,172IL-2 variants for the treatment of psoriasis
Lapsed on the fee record
Ended Aug 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 3, 2025From the USPTO record
US 11,059,877Multivalent regulatory T cell modulators
Lapsed on the fee record
Ended Jul 13, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 13, 2025From the USPTO record
US 10,875,901Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Lapsed on the fee record
Ended Dec 29, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 29, 2024From the USPTO record
US 10,774,126Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Lapsed on the fee record
Ended Sep 15, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 15, 2024From the USPTO record
US 10,766,938Nucleic acid encoding human IL-2 variant
Lapsed on the fee record
Ended Sep 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 8, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited